Randomized Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) (ADVANCE)

Type of Cancer
Breast Oncology

Site
Bethesda

Sponsor
Spectrum Pharmaceuticals

Protocol Number
SPI-GCF-301

To Learn More Call
201-510-0910